Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A;Langzeittherapie fokaler dystonien und des hemispasmus facialis mit botulinum-toxin A

Nervenarzt

Volumn 79, Issue 8, 2008, Pages 912-917

  Vogt, T ^a   Lussi F ^a   Paul, A ^a   Urban, P ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Asklepios Klinik   (Germany)

Author keywords

Botulinum toxin; Focal dystonia; Long term treatment

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; BLEPHAROSPASM; CONTROLLED STUDY; DOSE RESPONSE; DYSTONIA; FOCAL DYSTONIA; HEMIFACIAL SPASM; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; SPASMODIC TORTICOLLIS; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIC DISORDERS; FEMALE; HEMIFACIAL SPASM; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME;

EID: 49249129595     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-008-2486-2     Document Type: Article

References (20)

1. Ceballos 1990 Nervenarzt 61 604
2. Defazi 2002 Arch Neurol 59 418
3. Dressler 1989 Nervenarzt 60 386
4. Dressler 1998 J Neurol 245 332
5. Dressler D, Benecke R (2004) Antikörpervermitteltes versagen der Botulinumtoxin Therapie. In: Laskawi R, Roggenkämper P (Hrgs) Botulinumtoxin-Therapie im Kopf-Hals-Bereich. Urban & Vogel, München
6. Dutton 1996 Surv Ophthalmol 41 51
7. Elston 1986 J Neurol Neurosurg Psychiatry 49 827
8. Frueh 1984 Arch Ophthalmol 102 1464
9. Greene 1994 Mov Disord 9 213
10. Herrmann 2004 Ann Neurol 55 732
11. Hsiung 2002 Mov Disord 6 1288
12. Jankovic 1984 Ann Ophthalmol 16 371
13. Kessler 1999 J Neurol 246 265
14. Kranz 2008 Neurology 70 133
15. Kruisdijk 2007 J Neurol Neurosurg Psychiatry 78 264
16. Mejia 2005 Mov Disord 20 592
17. Nüßgens 1995 German J Ophthlamol 4 363
18. Snir 2003 Am J Ophthalmol 136 99
19. Tsui 1986 Lancet 2 245
20. Wissel 2001 J Neurol 248 1073